Insomnia: Recent Advances in Genetic Aspects and Therapies
Biomedical Research and Therapy · 30.04.2023 · 10 (4) · 5630-5637
DOI: 10.15419/bmrat.v10i4.804 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Research and Therapy, online erschienen am 30.04.2023. Verfasst von Maryam Riasat und 7 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref).
Themen: Schlaf
Abstract (Originalsprache)
Insomnia has a significant global incidence rate. Previous observational studies, general practitioner surveys, and medical trials suggest that a variety of patient and physician factors are associated with this, including low patient reporting of insomnia, limited healthcare professional training, office-based time constraints, and misconceptions about the seriousness of insomnia, treatment benefits, and the risks associated with hypnotic use. Here, we discuss the recently studied genetic aspects of insomnia pathogenesis and the orexin system and acupuncture as potential therapeutic strategies.
Zitieren
APA
Riasat, M., Afzal, A., Khawar, M. B., Hamid, S. E., Habiba, U., Shahzaman, S., Shahid, N., & Naseem, R. (2023). Insomnia: Recent Advances in Genetic Aspects and Therapies. Biomedical Research and Therapy, 10(4), 5630-5637. https://doi.org/10.15419/bmrat.v10i4.804
Vancouver
Riasat M, Afzal A, Khawar MB, Hamid SE, Habiba U, Shahzaman S, et al. Insomnia: Recent Advances in Genetic Aspects and Therapies. Biomedical Research and Therapy. 2023;10(4):5630-5637. doi:10.15419/bmrat.v10i4.804
BibTeX
@article{Riasat2023,
author = {Riasat, Maryam and Afzal, Ali and Khawar, Muhammad Babar and Hamid, Syeda Eisha and Habiba, Ume and Shahzaman, Sara and Shahid, Nayab and Naseem, Rimsha},
title = {Insomnia: Recent Advances in Genetic Aspects and Therapies},
journal = {Biomedical Research and Therapy},
year = {2023},
volume = {10},
number = {4},
pages = {5630--5637},
doi = {10.15419/bmrat.v10i4.804}
}
EUVIMED